Futura Medical (FUM) Competitors GBX 11.75 +0.75 (+6.84%) As of 11:43 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock FUM vs. AVCT, TILS, VSN, SCLP, OBI, MPH, HVO, ORPH, REDX, and ETXShould you be buying Futura Medical stock or one of its competitors? The main competitors of Futura Medical include Avacta Group (AVCT), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), Ondine Biomedical (OBI), Mereo BioPharma Group plc (MPH.L) (MPH), hVIVO (HVO), Open Orphan (ORPH), Redx Pharma (REDX), and e-therapeutics (ETX). These companies are all part of the "biotechnology" industry. Futura Medical vs. Its Competitors Avacta Group Tiziana Life Sciences Verseon Scancell Ondine Biomedical Mereo BioPharma Group plc (MPH.L) hVIVO Open Orphan Redx Pharma e-therapeutics Avacta Group (LON:AVCT) and Futura Medical (LON:FUM) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends. Does the media favor AVCT or FUM? In the previous week, Futura Medical had 1 more articles in the media than Avacta Group. MarketBeat recorded 1 mentions for Futura Medical and 0 mentions for Avacta Group. Avacta Group's average media sentiment score of 0.00 equaled Futura Medical'saverage media sentiment score. Company Overall Sentiment Avacta Group Neutral Futura Medical Neutral Is AVCT or FUM more profitable? Futura Medical has a net margin of -44.64% compared to Avacta Group's net margin of -114.45%. Futura Medical's return on equity of -56.44% beat Avacta Group's return on equity.Company Net Margins Return on Equity Return on Assets Avacta Group-114.45% -74.00% -21.80% Futura Medical -44.64%-56.44%-26.59% Which has more risk & volatility, AVCT or FUM? Avacta Group has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Futura Medical has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Which has preferable valuation and earnings, AVCT or FUM? Futura Medical has lower revenue, but higher earnings than Avacta Group. Futura Medical is trading at a lower price-to-earnings ratio than Avacta Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvacta Group£26.29M4.88-£30.08M-£7.77-4.34Futura Medical£8.68M4.22-£3.88M-£1.21-9.69 Do insiders & institutionals believe in AVCT or FUM? 10.2% of Avacta Group shares are owned by institutional investors. Comparatively, 35.7% of Futura Medical shares are owned by institutional investors. 32.9% of Avacta Group shares are owned by insiders. Comparatively, 32.1% of Futura Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryFutura Medical beats Avacta Group on 7 of the 12 factors compared between the two stocks. Get Futura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for FUM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FUM vs. The Competition Export to ExcelMetricFutura MedicalBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£36.63M£132.03M£5.52B£3.04BDividend Yield4.55%3.74%4.00%5.02%P/E Ratio-9.693.5926.96167.03Price / Sales4.224,446.42446.24282,375.30Price / Cash20.4313.1924.9927.97Price / Book4.5440.208.144.58Net Income-£3.88M-£90.99M£3.24B£5.90B7 Day Performance2.55%1.31%1.12%0.59%1 Month Performance30.87%6.01%8.39%9.76%1 Year Performance-66.08%177.54%34.01%70.76% Futura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FUMFutura MedicalN/AGBX 11.75+6.8%N/A-68.3%£36.63M£8.68M-9.6912Gap UpHigh Trading VolumeAVCTAvacta GroupN/AGBX 32.25+0.8%N/A-55.5%£122.51M£26.29M-4.15120Gap UpTILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpSCLPScancellN/AGBX 10.16-0.9%N/A-21.3%£105.23MN/A-15.5851Gap UpOBIOndine BiomedicalN/AC$14.50flatN/A+53.9%C$104.26MC$48.60K-4.37N/AMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownHVOhVIVON/AGBX 10.70+7.0%N/A-67.3%£75.71M£68.74M4.41N/AORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179REDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295K-450.0035High Trading Volume Related Companies and Tools Related Companies AVCT Alternatives TILS Alternatives VSN Alternatives SCLP Alternatives OBI Alternatives MPH Alternatives HVO Alternatives ORPH Alternatives REDX Alternatives ETX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:FUM) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Futura Medical plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Futura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
